Cancer cells manipulate the body’s energy systems to grow and resist treatment, and researchers now understand this happens through communication between tumors and healthy tissues throughout the body. According to Gram Research analysis of the 6th International Metabolism and Cancer Symposium, 240 experts from 11 countries identified four key areas where cancer exploits metabolism: through diet and gut bacteria, by changing how cancer cells use energy to survive, through genetic control mechanisms, and by developing resistance to drugs. This whole-body metabolic approach is reshaping how scientists think about cancer treatment.
Scientists from 11 countries gathered in France to discuss how cancer cells hijack the body’s metabolism, or the way our bodies use food for energy. According to Gram Research analysis, the 240 experts explored four major areas: how diet and gut bacteria affect cancer, how cancer cells change their identity to survive, how genes are controlled in cancer, and how tumors resist treatment. The key insight is that cancer doesn’t just happen in one spot in the body. Instead, it’s a whole-body problem where tumors communicate with healthy tissues and change how the entire body processes energy. This understanding could lead to new, personalized cancer treatments that target these metabolic weaknesses.
Key Statistics
The 6th International Metabolism and Cancer Symposium in 2025 brought together 240 cancer researchers from 11 countries to discuss how tumors manipulate the body’s energy systems to grow and resist treatment.
A 2025 international conference of 240 cancer experts identified that cancer cells communicate with healthy tissues throughout the body to reprogram whole-organism metabolism, representing a fundamental shift from viewing cancer as a local disease.
Scientists at the 2025 Metabolism and Cancer Symposium highlighted that the gut microbiome, diet, and tissue environment around tumors all influence cancer growth, suggesting future treatments may target these metabolic vulnerabilities.
The 6th Metabolism and Cancer conference in 2025 emphasized that cancer cells can change their metabolic identity to survive in different body locations and escape treatment, explaining why drug resistance develops.
The Quick Take
- What they studied: How cancer cells use the body’s energy systems to grow, survive, and resist treatment, and how this connects to diet, gut bacteria, and the body’s overall metabolism.
- Who participated: 240 cancer researchers and experts from 11 countries attended a three-day scientific conference in France in October 2025. These were leading scientists studying how cancer metabolism works.
- Key finding: Cancer is not just a local disease in one part of the body. Instead, tumors communicate with healthy tissues throughout the body and change how the entire organism uses energy. This whole-body connection is critical for understanding tumor growth and treatment resistance.
- What it means for you: Future cancer treatments may work better by targeting how tumors manipulate the body’s energy systems rather than just attacking cancer cells directly. This could lead to more effective, personalized therapies with fewer side effects. However, these are early-stage research directions, not yet available treatments.
The Research Details
This was a meeting report from the 6th International Metabolism and Cancer Symposium, held October 8-10, 2025, in La Grande Motte, France. Rather than a traditional research study with patients or lab experiments, this was a conference where 240 leading scientists presented and discussed the latest findings in cancer metabolism research. The conference featured 29 scientific presentations, including 15 keynote lectures from world experts. The presentations were organized into four focused topic areas to help researchers share knowledge and identify new research directions.
The conference structure allowed scientists to discuss cutting-edge discoveries about how cancer cells use energy differently than normal cells, how the gut microbiome influences cancer, how cancer cells can change their characteristics to survive treatment, and how tumors develop resistance to drugs. By bringing together experts from multiple countries and disciplines, the conference aimed to identify gaps in current knowledge and chart new directions for cancer research.
This type of meeting report is valuable because it synthesizes the latest research from leading experts and identifies emerging trends before they appear in individual published studies. It shows where the field is heading and what questions scientists think are most important. Understanding these research directions helps doctors and patients know what new treatments might be coming and what scientists believe will be most impactful for improving cancer care.
This report represents the collective expertise of 240 leading cancer researchers from 11 countries, which is a strong indicator of scientific credibility. However, this is a summary of a conference, not original research data. The findings discussed represent the current state of the field but are not new discoveries from this meeting itself. The value lies in identifying research priorities and emerging concepts rather than presenting new experimental results. Readers should view this as a roadmap of where cancer metabolism research is heading, not as proof that specific new treatments work.
What the Results Show
The conference identified four major areas where cancer metabolism research is advancing. First, scientists are learning how diet, gut bacteria, and the tissue environment around tumors all influence cancer growth and survival. The gut microbiome, which is the collection of bacteria living in your digestive system, appears to play a larger role in cancer than previously understood.
Second, researchers discussed how cancer cells have remarkable flexibility. Cancer cells can change their metabolic identity, meaning they can switch how they use energy and nutrients to survive in different parts of the body and to escape treatment. This plasticity, or ability to change, is a major reason why cancer is so difficult to treat.
Third, scientists explored how genes are controlled in cancer cells through epigenetics and epitranscriptomics, which are mechanisms that turn genes on and off without changing the DNA sequence itself. These control systems appear to be closely linked to how cancer cells use energy.
Fourth, the conference highlighted that tumors develop resistance to drugs partly by changing their metabolism. Understanding these metabolic changes could reveal new ways to prevent or overcome drug resistance.
A critical emerging concept is that cancer should be understood as a whole-body disease, not just a local problem. Tumors actively communicate with healthy tissues throughout the body and reprogram how the entire organism uses energy. This systemic approach means that treatments targeting only the tumor itself may miss important factors that allow cancer to grow and spread. The conference emphasized that future progress requires studying how tumors and the rest of the body interact metabolically.
This conference builds on decades of cancer research but represents a shift in perspective. Earlier cancer research focused heavily on the genetic mutations inside cancer cells. This meeting shows that the field is increasingly recognizing that cancer cells’ ability to manipulate energy use and communicate with the body’s tissues is equally important. The emphasis on the microbiome, diet, and whole-body metabolism reflects growing evidence that these factors significantly influence cancer outcomes. This represents a maturation of cancer metabolism as a field, moving from describing how cancer cells are different to identifying actionable targets for new treatments.
As a conference report rather than original research, this summary does not present new experimental data or clinical trial results. The findings discussed represent current expert opinions and recent research, but individual studies may have limitations not detailed here. The conference focused on emerging research directions, which means some discussed concepts are still in early stages and may not lead to practical treatments. Additionally, most of the research discussed likely comes from laboratory studies or animal models, so translation to human patients requires further investigation. Readers should understand this as a scientific roadmap, not a guide to available treatments.
The Bottom Line
Based on this conference summary, the strongest recommendation is to stay informed about emerging cancer metabolism research if you or a loved one is dealing with cancer. Current evidence suggests that diet, gut health, and overall lifestyle may influence cancer outcomes, though specific dietary recommendations require more research. If you have cancer, discuss with your oncologist whether any emerging metabolic approaches might be appropriate for your specific situation. For cancer prevention, maintaining a healthy diet, regular physical activity, and good gut health remain evidence-based strategies. Confidence level: moderate for prevention strategies, lower for specific metabolic treatments, which are still largely in research phases.
Cancer patients and survivors should be most interested in this research, as it may lead to new treatment options. People with family histories of cancer may benefit from understanding these emerging prevention strategies. Oncologists and cancer researchers will find this especially relevant for their work. Healthcare providers interested in precision medicine and personalized treatment should follow this field. The general public should be aware that cancer research is evolving toward more sophisticated, personalized approaches.
Most of the metabolic approaches discussed at this conference are still in research phases. It typically takes 5 to 10 years for laboratory discoveries to become available clinical treatments. Some approaches may be available in clinical trials within 2 to 3 years. Dietary and lifestyle modifications based on current evidence could have effects within weeks to months. Readers should not expect major new cancer treatments based on this conference to be widely available immediately, but should watch for clinical trials testing these approaches over the next few years.
Frequently Asked Questions
How does cancer use the body’s metabolism to survive?
Cancer cells reprogram how the body uses energy and nutrients. They communicate with healthy tissues to change whole-body metabolism in ways that support tumor growth. They can also switch between different energy sources to survive in different environments and escape treatment.
Can diet affect cancer growth based on recent research?
Research suggests diet influences cancer through multiple pathways, including effects on gut bacteria and whole-body metabolism. A 2025 international conference of 240 experts identified diet as one of four major areas where cancer metabolism can be targeted, though specific dietary recommendations for cancer patients require consultation with oncologists.
What role does the gut microbiome play in cancer?
The gut microbiome, which is the bacteria living in your digestive system, appears to significantly influence cancer development and treatment response. Scientists at the 2025 Metabolism and Cancer Symposium identified the microbiome as a key factor in how tumors grow and how the body responds to cancer therapy.
When will new cancer treatments based on metabolism research be available?
Most metabolic approaches discussed at the 2025 conference are still in research phases. Laboratory discoveries typically take 5 to 10 years to become available treatments. Some approaches may enter clinical trials within 2 to 3 years, but widespread availability will likely take longer.
Is cancer a whole-body disease or just a local problem?
According to 240 cancer experts at the 2025 Metabolism and Cancer Symposium, cancer should be understood as a whole-body disease. Tumors actively communicate with healthy tissues throughout the body and reprogram how the entire organism uses energy, making systemic approaches to treatment increasingly important.
Want to Apply This Research?
- Track daily diet composition (percentage of protein, fat, carbohydrates), weekly physical activity minutes, and monthly weight changes. Also monitor digestive health indicators like bowel regularity and energy levels. This data could become relevant if you’re enrolled in a clinical trial testing metabolic approaches to cancer prevention or treatment.
- Start a food and symptom journal to identify how different foods affect your energy, digestion, and overall wellbeing. Focus on increasing fiber intake through whole grains, vegetables, and fruits to support healthy gut bacteria. Aim for 150 minutes of moderate physical activity weekly. These changes support overall metabolic health while researchers continue developing targeted metabolic cancer treatments.
- Use the app to establish baseline measurements of diet quality, activity level, and digestive health over 4 weeks. Then track these metrics monthly to identify patterns. If you’re participating in cancer-related research or treatment, share this data with your healthcare team to help them understand how lifestyle factors correlate with your health outcomes. This longitudinal tracking will become increasingly valuable as personalized metabolic cancer treatments develop.
This article summarizes a scientific conference report and does not represent new clinical research or treatment recommendations. The findings discussed are emerging research directions, not proven treatments. If you have cancer or are at risk for cancer, consult with your oncologist or healthcare provider before making any changes to diet, supplements, or treatment plans. Do not delay or replace conventional cancer treatment based on information in this article. Some of the research discussed is preliminary and may not translate to human treatments. Always seek personalized medical advice from qualified healthcare professionals regarding your individual cancer risk or diagnosis.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.